CORCEPT THERAPEUTICS INC - Common Stock (CORT)

CUSIP: 218352102

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / Common Stock
Shares outstanding
105,274,735
Total 13F shares
29,700,124
Share change
-767,416
Total reported value
$83,152,770
Put/Call ratio
0%
Price per share
$2.80
Number of holders
61
Value change
-$5,827,268
Number of buys
31
Number of sells
29

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CORT - CORCEPT THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13F
Company
12%
12,233,892
$53,340,000 31 Mar 2014
13F
INVESTOR AB
13F
Company
3.3%
3,454,745
$15,063,000 31 Mar 2014
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
2.2%
2,324,499
$10,135,000 31 Mar 2014
13F
JENNISON ASSOCIATES LLC
13F
Company
2%
2,151,617
$9,381,000 31 Mar 2014
13F
VANGUARD GROUP INC
13F
Company
2%
2,129,395
$9,284,000 31 Mar 2014
13F
BlackRock Fund Advisors
13F
Company
1.4%
1,488,215
$6,489,000 31 Mar 2014
13F
MORGAN STANLEY
13F
Company
1.4%
1,485,214
$6,475,000 31 Mar 2014
13F
STATE STREET CORP
13F
Company
0.76%
797,148
$3,477,000 31 Mar 2014
13F
NORTHERN TRUST CORP
13F
Company
0.62%
656,126
$2,861,000 31 Mar 2014
13F
TFS CAPITAL LLC
13F
Company
0.48%
502,989
$2,193,000 31 Mar 2014
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.37%
387,407
$1,689,000 31 Mar 2014
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.33%
352,384
$1,536,000 31 Mar 2014
13F
Bank of New York Mellon Corp
13F
Company
0.24%
250,847
$1,094,000 31 Mar 2014
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.19%
203,658
$888,000 31 Mar 2014
13F
UBS AG
13F
Company
0.15%
160,131
$698,000 31 Mar 2014
13F
BlackRock Investment Management, LLC
13F
Company
0.14%
147,964
$645,000 31 Mar 2014
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.15%
153,500
$641,000 31 Mar 2014
13F
BARCLAYS PLC
13F
Company
0.11%
119,004
$476,000 31 Mar 2014
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
101,500
$443,000 31 Mar 2014
13F
GABELLI & Co INVESTMENT ADVISERS, INC.
13F
Company
0.09%
100,000
$436,000 31 Mar 2014
13F
TEACHERS ADVISORS, LLC
13F
Company
0.09%
97,408
$425,000 31 Mar 2014
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.09%
95,885
$418,000 31 Mar 2014
13F
DEUTSCHE BANK AG\
13F
Company
0.09%
90,175
$392,000 31 Mar 2014
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.07%
77,700
$339,000 31 Mar 2014
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.06%
68,400
$299,000 31 Mar 2014
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.06%
58,900
$257,000 31 Mar 2014
13F
ProShare Advisors LLC
13F
Company
0.05%
53,896
$235,000 31 Mar 2014
13F
CAMBRIDGE TRUST CO
13F
Company
0.05%
50,000
$218,000 31 Mar 2014
13F
CREDIT SUISSE AG/
13F
Company
0.05%
49,264
$215,000 31 Mar 2014
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0.04%
47,179
$206,000 31 Mar 2014
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.04%
45,749
$200,000 31 Mar 2014
13F
BLACKROCK ADVISORS LLC
13F
Company
0.04%
44,763
$195,000 31 Mar 2014
13F
GROUP ONE TRADING LLC
13F
Company
0.04%
44,638
$195,000 31 Mar 2014
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
43,505
$190,000 31 Mar 2014
13F
Nationwide Fund Advisors
13F
Company
0.04%
41,520
$181,000 31 Mar 2014
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
39,080
$170,000 31 Mar 2014
13F
TCW GROUP INC
13F
Company
0.04%
37,048
$162,000 31 Mar 2014
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
36,193
$157,801 31 Mar 2014
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.03%
29,555
$129,000 31 Mar 2014
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.03%
27,717
$121,000 31 Mar 2014
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.03%
27,202
$119,000 31 Mar 2014
13F
MENTA CAPITAL LLC
13F
Company
0.02%
24,100
$105,000 31 Mar 2014
13F
BUCKINGHAM STRATEGIC WEALTH, LLC
13F
Company
0.02%
20,000
$87,000 31 Mar 2014
13F
SAC Capital Advisors LP
13F
Company
0.01%
14,329
$62,000 31 Mar 2014
13F
Nine Chapters Capital Management LLC
13F
Company
0.01%
14,000
$61,000 31 Mar 2014
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
11,539
$50,000 31 Mar 2014
13F
NATIXIS
13F
Company
0.01%
11,500
$50,000 31 Mar 2014
13F
WEDBUSH SECURITIES INC
13F
Company
0.01%
11,000
$48,000 31 Mar 2014
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.01%
10,721
$47,000 31 Mar 2014
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.01%
10,383
$45,000 31 Mar 2014
13F

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2014

As of 30 Jun 2014, CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,700,124 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, INVESTOR AB, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Fund Advisors, State Street Corp, NORTHERN TRUST CORP, Catalyst Capital Advisors LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders
58
Q2 2014 holders
61
Holder diff
3
Investor Q1 2014 Shares Q2 2014 Shares Share Diff Share Chg % Q1 2014 Value $ Q2 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.